Signal Pathways Mediating Antidepressant and Antipsychotic Drugs on Neuronal Cell Survival
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
4
Page:
105-118
Author(s):
Anke Post, Osborne F.X. Almeida and Florian Holsboer
Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
4
Page:
119-137
Author(s):
Jaime M. Monti
Amine Oxidase Inhibitors and Development of Neuroprotective Drugs
Journal:
Current Neuropharmacology
Volume:
2
Page:
153-168
Author(s):
Bernard N. Sowa, Kathryn G. Todd, A. M. I Tanay, Andrew Holt and Glen B. Baker
Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
679-686
Author(s):
M. Thomas and W. D. Le
Novel Therapeutic Effects of the Anti-Convulsant, Zonisamide, on Parkinsons Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
687-693
Author(s):
M. Murata
Nicotine and Nicotinic Receptor Involvement in Neuropsychiatric Disorders
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
267-282
Author(s):
P. Newhouse, A. Singh and and A. Potter
Pharmacological Studies of Smooth Pursuit and Antisaccade Eye Movements in Schizophrenia: Current Status and Directions for Future Research
Journal:
Current Neuropharmacology
Volume:
1
Page:
285-300
Author(s):
Ulrich Ettinger and Veena Kumari
Genetic Factors in Parkinsons Disease and Potential Therapeutic Targets
Journal:
Current Neuropharmacology
Volume:
1
Page:
301-313
Author(s):
Jian Feng
[General Articles] Cannabinoids: Mechanisms and Therapeutic Applications in the CNS
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
2719-2732
Author(s):
Alison J. Drysdale and Bettina Platt
Exploring Genetic Influences on Cognition: Emerging Strategies for Target Validation and Treatment Optimization
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
2
Page:
357-362
Author(s):
John A. Fossella, Sonia Bishop and B. J. Casey